{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:55Z","timestamp":1790186515154,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11102-024-01387-y","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T17:01:30Z","timestamp":1711213290000},"page":"294-302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Changes in multi-modality management of acromegaly in a tertiary centre over 2 decades"],"prefix":"10.1007","volume":"27","author":[{"given":"V.","family":"Amodru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Sahakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Piazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vermalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Regis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"F.","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,23]]},"reference":[{"issue":"6","key":"1387_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ando.2023.08.003","volume":"84","author":"T Brue","year":"2023","unstructured":"Brue T, Rahabi H, Barry A, Barlier A, Bertherat J, Borson-Chazot F et al (2023) Position statement on the diagnosis and management of acromegaly: the French National Diagnosis and Treatment Protocol (NDTP). Ann Endocrinol (Paris) 84(6):697\u2013710. https:\/\/doi.org\/10.1016\/j.ando.2023.08.003","journal-title":"Ann Endocrinol (Paris)"},{"issue":"24","key":"1387_CR2","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558\u20132573. https:\/\/doi.org\/10.1056\/NEJMra062453","journal-title":"N Engl J Med"},{"issue":"1","key":"1387_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152. https:\/\/doi.org\/10.1210\/er.2002-0022","journal-title":"Endocr Rev"},{"issue":"5","key":"1387_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1530\/EJE-16-1064","volume":"176","author":"L Maione","year":"2017","unstructured":"Maione L, Brue T, Beckers A, Delemer B, Petrossians P, Borson-Chazot F et al (2017) Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry. Eur J Endocrinol 176(5):645\u2013655. https:\/\/doi.org\/10.1530\/EJE-16-1064","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1387_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.02.001","volume":"33","author":"L Maione","year":"2019","unstructured":"Maione L, Chanson P (2019) National acromegaly registries. Best Pract Res Clin Endocrinol Metab 33(2):101264. https:\/\/doi.org\/10.1016\/j.beem.2019.02.001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"1387_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12020-018-1764-4","volume":"63","author":"P Caron","year":"2019","unstructured":"Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B et al (2019) Signs and symptoms of acromegaly at diagnosis: the physician\u2019s and the patient\u2019s perspectives in the ACRO-POLIS study. Endocrine 63(1):120\u2013129. https:\/\/doi.org\/10.1007\/s12020-018-1764-4","journal-title":"Endocrine"},{"issue":"1","key":"1387_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","volume":"24","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1\u201313. https:\/\/doi.org\/10.1007\/s11102-020-01091-7","journal-title":"Pituitary"},{"issue":"4","key":"1387_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/EJE-21-0239","volume":"185","author":"M Fleseriu","year":"2021","unstructured":"Fleseriu M, Fuhrer-Sakel D, van der Lely AJ, De Marinis L, Brue T, van der Lans-Bussemaker J et al (2021) More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY. Eur J Endocrinol 185(4):525\u2013538. https:\/\/doi.org\/10.1530\/EJE-21-0239","journal-title":"Eur J Endocrinol"},{"key":"1387_CR9","doi-asserted-by":"publisher","unstructured":"Kerbel J, Cano-Zaragoza A, Espinosa-Dorado R, Garcia de la Torre KE, Mercado M. 2023 Real World Data on the Epidemiology, Diagnosis, and Treatment of Acromegaly: A Registries-based Approach. Arch Med Res. 54(6): 102856. https:\/\/doi.org\/10.1016\/j.arcmed.2023.102856","DOI":"10.1016\/j.arcmed.2023.102856"},{"issue":"2","key":"1387_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2265.2012.04492.x","volume":"78","author":"F Albarel","year":"2013","unstructured":"Albarel F, Castinetti F, Morange I, Conte-Devolx B, Gaudart J, Dufour H et al (2013) Outcome of multimodal therapy in operated acromegalic patients, a study in 115 patients. Clin Endocrinol (Oxf) 78(2):263\u2013270. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04492.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1387_CR11","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3171\/2014.12.JNS141083","volume":"122","author":"AS Micko","year":"2015","unstructured":"Micko AS, Wohrer A, Wolfsberger S, Knosp E (2015) Invasion of the cavernous sinus space in pituitary adenomas: endoscopic verification and its correlation with an MRI-based classification. J Neurosurg 122(4):803\u2013811. https:\/\/doi.org\/10.3171\/2014.12.JNS141083","journal-title":"J Neurosurg"},{"issue":"1","key":"1387_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126(1):123\u2013135. https:\/\/doi.org\/10.1007\/s00401-013-1084-y","journal-title":"Acta Neuropathol"},{"issue":"9","key":"1387_CR13","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F et al (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368\u20133374. https:\/\/doi.org\/10.1210\/jc.2017-00773","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1387_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","volume":"72","author":"TJ Reid","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203\u2013208. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03626.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"1387_CR15","first-page":"660","volume":"100","author":"O Dupuy","year":"2007","unstructured":"Dupuy O, Petrossian T, Bordier L, Mayaudon H, Bauduceau B (2007) Hypertension and acromegaly in the elderly: French registry data. Arch Mal Coeur Vaiss 100(8):660\u2013663","journal-title":"Arch Mal Coeur Vaiss"},{"issue":"4","key":"1387_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1530\/EJE-07-0358","volume":"157","author":"M Bex","year":"2007","unstructured":"Bex M, Abs R, T\u2019Sjoen G, Mockel J, Velkeniers B, Muermans K et al (2007) AcroBel\u2013the Belgian registry on acromegaly: a survey of the \u201creal-life\u201d outcome in 418 acromegalic subjects. Eur J Endocrinol 157(4):399\u2013409. https:\/\/doi.org\/10.1530\/EJE-07-0358","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1387_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1530\/EJE-12-0084","volume":"167","author":"M Arosio","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, Berchialla P, Borraccino A, De Marinis L et al (2012) Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol 167(2):189\u2013198. https:\/\/doi.org\/10.1530\/EJE-12-0084","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1387_CR18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S et al (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439\u2013446. https:\/\/doi.org\/10.1530\/eje.0.1510439","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1387_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11102-012-0384-x","volume":"16","author":"G Sesmilo","year":"2013","unstructured":"Sesmilo G, Gaztambide S, Venegas E, Pico A, Del Pozo C, Blanco C et al (2013) Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA). Pituitary 16(1):115\u2013121. https:\/\/doi.org\/10.1007\/s11102-012-0384-x","journal-title":"Pituitary"},{"issue":"4","key":"1387_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/cen.12020","volume":"78","author":"O Kwon","year":"2013","unstructured":"Kwon O, Song YD, Kim SY, Lee EJ (2013) Rare disease study group S, research committee KES nationwide survey of acromegaly in South Korea. Clin Endocrinol (Oxf). 78(4):577\u201385. https:\/\/doi.org\/10.1111\/cen.12020","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"1","key":"1387_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1530\/EJE-12-0602","volume":"168","author":"C Schofl","year":"2013","unstructured":"Schofl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B et al (2013) Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register. Eur J Endocrinol 168(1):39\u201347. https:\/\/doi.org\/10.1530\/EJE-12-0602","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"1387_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11102-023-01322-7","volume":"26","author":"TNA Slagboom","year":"2023","unstructured":"Slagboom TNA, van Bunderen CC, De Vries R, Bisschop PH, Drent ML (2023) Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines. Pituitary 26(4):319\u2013332. https:\/\/doi.org\/10.1007\/s11102-023-01322-7","journal-title":"Pituitary"},{"issue":"9","key":"1387_CR23","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1210\/jc.2008-2772","volume":"94","author":"F Castinetti","year":"2009","unstructured":"Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P et al (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9):3400\u20133407. https:\/\/doi.org\/10.1210\/jc.2008-2772","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1387_CR24","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1210\/clinem\/dgz187","volume":"105","author":"A Ghajar","year":"2020","unstructured":"Ghajar A, Jones PS, Guarda FJ, Faje A, Tritos NA, Miller KK et al (2020) Biochemical control in acromegaly with multimodality therapies: outcomes from a pituitary center and changes over time. J Clin Endocrinol Metab 105(3):e532\u2013e543. https:\/\/doi.org\/10.1210\/clinem\/dgz187","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1387_CR25","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1210\/jc.2007-2149","volume":"93","author":"L Nachtigall","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93(6):2035\u20132041. https:\/\/doi.org\/10.1210\/jc.2007-2149","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1387_CR26","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1210\/jc.2010-2443","volume":"96","author":"L Sandret","year":"2011","unstructured":"Sandret L, Maison P, Chanson P (2011) Place of cabergoline in acromegaly: a meta-analysis. J Clin Endocrinol Metab 96(5):1327\u20131335. https:\/\/doi.org\/10.1210\/jc.2010-2443","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1387_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s11102-018-0916-0","volume":"21","author":"F Albarel","year":"2018","unstructured":"Albarel F, Castinetti F, Morange I, Guibert N, Graillon T, Dufour H et al (2018) Pre-surgical medical treatment, a major prognostic factor for long-term remission in acromegaly. Pituitary 21(6):615\u2013623. https:\/\/doi.org\/10.1007\/s11102-018-0916-0","journal-title":"Pituitary"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01387-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-024-01387-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-024-01387-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T08:14:56Z","timestamp":1717488896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-024-01387-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,23]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s11102-024-01387-y","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,23]]},"assertion":[{"value":"16 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Thierry Brue has received conference\/consultancy fees and\/or research grants from Association Fran\u00e7aise contre les Myopathies (AFM Telethon), Ipsen, Lilly, Novartis, Novo-Nordisk, Pfizer and Recordati, and served as clinical trial investigator for Crinetics, Debiopharm, Recordati and Xeris. Frederic Castinetti has received conference\/consultancy fees and\/or research grants from Ipsen, Recordati rare diseases, and served as clinical trial investigator for Recordati rare diseases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}